美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 32 条
共 2 页，当前第 2 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| LINEZOLID |
207354 |
002 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
600MG/300ML (2MG/ML) |
No
|
No
|
2016/12/20
|
2016/12/20
|
NANG KUANG PHARM CO |
Prescription |
| LINEZOLID |
206097 |
001 |
ANDA |
LINEZOLID |
TABLET;ORAL |
600MG |
No
|
No
|
2017/02/22
|
2017/02/22
|
ZYDUS PHARMS |
Prescription |
| LINEZOLID |
204696 |
001 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
200MG/100ML (2MG/ML) |
No
|
No
|
2017/03/02
|
2017/03/02
|
SAGENT PHARMS INC |
Prescription |
| LINEZOLID |
204696 |
002 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
600MG/300ML (2MG/ML) |
No
|
No
|
2017/03/02
|
2017/03/02
|
SAGENT PHARMS INC |
Prescription |
| LINEZOLID |
207001 |
001 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
200MG/100ML (2MG/ML) |
No
|
No
|
2017/07/07
|
2017/07/07
|
HQ SPCLT PHARMA |
Prescription |
| LINEZOLID |
207001 |
002 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
600MG/300ML (2MG/ML) |
No
|
No
|
2017/07/07
|
2017/07/07
|
HQ SPCLT PHARMA |
Prescription |
| LINEZOLID |
205154 |
001 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
200MG/100ML (2MG/ML) |
No
|
No
|
2017/12/06
|
2017/12/06
|
MYLAN LABS LTD |
Prescription |
| LINEZOLID |
205154 |
002 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
600MG/300ML (2MG/ML) |
No
|
No
|
2017/12/06
|
2017/12/06
|
MYLAN LABS LTD |
Prescription |
| LINEZOLID |
210702 |
001 |
ANDA |
LINEZOLID |
TABLET;ORAL |
600MG |
No
|
No
|
2019/04/25
|
2019/04/25
|
CHARTWELL RX |
Prescription |
| LINEZOLID |
206454 |
001 |
ANDA |
LINEZOLID |
SOLUTION;INTRAVENOUS |
600MG/300ML (2MG/ML) |
No
|
No
|
2022/08/22
|
2022/08/22
|
HIKMA |
Prescription |
| LINEZOLID |
211813 |
001 |
ANDA |
LINEZOLID |
FOR SUSPENSION;ORAL |
100MG/5ML |
No
|
No
|
2022/10/31
|
2022/10/31
|
HETERO LABS |
Prescription |
| LINEZOLID |
210378 |
001 |
ANDA |
LINEZOLID |
TABLET;ORAL |
600MG |
No
|
No
|
2024/10/10
|
2024/10/10
|
MACLEODS PHARMS LTD |
Prescription |